Articles

From 22 March 2023 changes to the Therapeutic Goods Act 1989 will help alleviate the effects of medicine shortages on patients.

Provisional registration of Tecentriq (atezolizumab) for the treatment in mTNBC will lapse on 22 March 2023.

The TGA is aware of concerns about decreased effectiveness of monoclonal antibodies against the COVID-19 caused by emerging SAR-COV-2 variants. At this stage, the regulatory status of the products remain unchanged in Australia.

In response to user feedback, we have been trialling a beta version of the DAEN – medicines since June 2022 alongside the older database.

Supplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.

New guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.

Current antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.

The Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.

The Prescribing Medicines in Pregnancy database has now been updated.

The Prescribing Medicines in Pregnancy database has now been updated.

The TGA will have limited operations from Friday 23 December 2022 until Tuesday 3 January 2023

Before you take a weight loss supplement or medicine, there are things to consider.

A warning to social media influencers and advertisers not to advertise this prescription medicine.

Find out more about the post market review the TGA is undertaking on spinal cord stimulators (SCS).

Find out about the requirements starting on 1 January 2023 for medicines that are serialised or include a data matrix code.

The TGA urges consumers to steer clear of using products containing 'Melanotan'

The Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.

Tell us your experience using of the beta Database of Adverse Event Notifications (DAEN) - medicines.

The TGA is providing guidance on surrogate viruses that may be used to test disinfectants making claims of efficacy against Monkeypox.

The TGA has approved the removal of the geographical deferral of blood and plasma donors from the UK, which was put in place to minimise the risk of variant Creutzfeldt-Jakob disease (vCJD), commonly known as 'mad cow disease'.

Questions and answers on Cannabis and Tetrahydrocannabinols